Teesside University announces new innovation partnership
The new agreement unites the university’s staff and students with industry partners in the biosciences sector
Teesside University has announced a new innovation partnership with CPI.
The three-year biosciences agreement will enable the partners to strengthen the sector in the North East, share facilities and collaborate on new research projects.
Teesside’s pro-vice-chancellor for enterprise and business engagement, Prof Jane Turner, said the agreement would “ensure the ambition and intent within the Local Industrial Strategy is realised”.
CPI is a founding member of the government’s High Value Manufacturing Catapult and works to bridge the gap between researchers and those in industry who can successfully market new innovations.
By working more strategically in partnership with Teesside University we can accelerate the provision of the knowledge and infrastructure that attracts, supports and grows companies
– Nigel Perry, CPI
Teesside already has some specific agreements with CPI, including the on-going THYME project, which is developing augmented reality and virtual reality training tools for bioprocess operator training.
The university recently opened its £22.3m National Horizons Centre (NHC), a flagship research, teaching and training facility for the biosciences.
Prof Stephen Cummings, dean of school of science, engineering and design, said: “With the opening of the NHC, alongside our ground-breaking research, collaboration and knowledge exchange activity, Teesside University is establishing itself as a leading force within the biosciences sector.
“We have worked alongside CPI successfully for a number of years but are delighted to formalise our partnership and provide even more opportunities for staff, students and partners.”
However well-prepared individual universities are, there is a huge amount only Government can do – and where they have yet to act, says Universities UK’s Vivienne Stern
Prof Gary Montague, professor of bioprocessing at Teesside, said: “Teesside University worked alongside CPI Biologics in the recently completed the £11.2M Biostreamline project where their collaboration resulted in developing a decision-making tool for early stage monoclonal antibody development.”
Nigel Perry, chief executive of CPI, said: “By working more strategically in partnership with Teesside University we can accelerate the provision of the knowledge and infrastructure that attracts, supports and grows companies and which helps to provide new jobs and new products for the UK.”
Got a news story for UB? Contact James Higgins on 0117 300 5526